Alzamend Neuro, Inc.

    ALZN ·NASDAQ ·Pharmaceutical Preparations ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-09-09 10-Q expected by 2026-09-12 (in 45 days)
    • ~2026-12-08 10-Q expected by 2026-12-11 (in 135 days)
    • ~2027-03-10 10-Q expected by 2027-03-13 (in 227 days)
    • ~2027-07-22 10-K expected by 2027-07-27 (in 361 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-07-22 10-K Annual Report
    • 2026-07-21 8-K Other Events; Financial Statements and Exhibits
    • 2026-03-20 8-K Delisting Notice; Financial Statements and Exhibits
    • 2026-03-11 10-Q Quarterly Report
    • 2026-03-06 8-K Material Agreement Entered; Financial Statements and Exhibits
    • 2025-12-09 10-Q Quarterly Report
    • 2025-11-18 8-K Other Events; Financial Statements and Exhibits
    • 2025-10-09 8-K Unregistered Equity Sale; Financial Statements and Exhibits
    • 2025-09-25 8-K Unregistered Equity Sale; Financial Statements and Exhibits
    • 2025-09-10 10-Q Quarterly Report
    • 2025-08-01 8-K Unregistered Equity Sale; Financial Statements and Exhibits
    • 2025-07-23 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-07-22 10-K Annual Report
    • 2025-03-27 S-1/A AMENDMENT NO. 1
    • 2025-03-13 S-3 Registration Statement